Mar 29, 2026Metabolic DiseaseSGLT2 Inhibitors vs GLP-1 Drugs: Kidney Study ResultsSGLT2 inhibitors beat GLP-1 drugs on some kidney outcomes, but mortality and albuminuria complicate the choice. What the first head-to-head study found today.sglt2 inhibitorsglp-1 receptor agoniststype 2 diabeteskidney protectionRead article →
Mar 23, 2026NutritionGut Microbiome Therapy in CKD: Promise, Not a Kidney CureA 53-study analysis and dialysis trial link prebiotics and synbiotics to lower toxins and better anemia markers—but evidence remains low-certainty.probioticssynbioticsgut microbiomeckdRead article →